Tyruko® – the new Natalizumab Biosimilar
Since some time ago, several oral MS drugs have been available as generics (see also MS-DocBlog Generics in MS therapy), since February 01, 2024, Tyruko® from Sandoz is also the first biosimilar approved and available
Continue reading